Use of allyl intermediate in novel synthetic route to rosuvastatin key heterocyclic building block: N-(4-(4-fluorophenyl)-5-formyl-6- isopropylpyrimidin-2-yl)-Nmethylmethanesulfonamide

Authors

  • Alen Čusak EN-FIST Center of Excellence, Trg osvobodilne fronte 13, 1000 Ljubljana, Slovenia. , EN-FIST center odličnosti, Trg osvobodilne fronte 13, 1000 Ljubljana, Slovenija.
  • Zdenko Časar University of Ljubljana, Faculty of Pharmacy, Aškerčeva cesta 7, p. p. 311, SI-1000 Ljubljana, Slovenia and Lek d.d., Sandoz Development Center Slovenia, Verovškova 57, 1526 Ljubljana, Slovenia. , Univerza v Ljubljani, Fakulteta za farmacijo, Aškerčeva cesta 7, p. p. 311, SI-1000 Ljubljana, Slovenija and Lek d.d., Sandozov razvojni center Slovenija, Verovškova 57, 1526 Ljubljana, Slovenija. https://orcid.org/0000-0002-6689-3353 (unauthenticated)
  • Damjan Šterk Lek d.d., Sandoz Development Center Slovenia, Verovškova 57, 1526 Ljubljana, Slovenia. , Lek d.d., Sandozov razvojni center Slovenija, Verovškova 57, 1526 Ljubljana, Slovenija.

DOI:

https://doi.org/10.18690/analipazu.7.1-2.18-23.2017

Keywords:

statins, rosuvastatin, heterocycles, pyrimidines

Abstract

A key building block of rosuvastatin was prepared via a novel synthetic method. Key feature of the presented synthetic approach is introduction of an allyl group into pyrimidine core at position 5. 5-Allyl substituted pyrimidine derivative can be transformed into title compound in three steps involving izomerisation of the allyl into alkene moiety, oxidation of the alkene moiety to the diol structure and oxidative cleavage of vicinal diol. Synthesis enables preparation of title compound in overall 60 % yield, which represents 88 % average yield per step by applying industrially acceptable reagents and mild conditions.

Author Biographies

  • Alen Čusak, EN-FIST Center of Excellence, Trg osvobodilne fronte 13, 1000 Ljubljana, Slovenia., EN-FIST center odličnosti, Trg osvobodilne fronte 13, 1000 Ljubljana, Slovenija.

    Ljubljana, Slovenia. E-mail: zdenko.casar@sandoz.com

  • Zdenko Časar, University of Ljubljana, Faculty of Pharmacy, Aškerčeva cesta 7, p. p. 311, SI-1000 Ljubljana, Slovenia and Lek d.d., Sandoz Development Center Slovenia, Verovškova 57, 1526 Ljubljana, Slovenia., Univerza v Ljubljani, Fakulteta za farmacijo, Aškerčeva cesta 7, p. p. 311, SI-1000 Ljubljana, Slovenija and Lek d.d., Sandozov razvojni center Slovenija, Verovškova 57, 1526 Ljubljana, Slovenija.

    Ljubljana, Slovenia. E-mail: zdenko.casar@sandoz.com

  • Damjan Šterk, Lek d.d., Sandoz Development Center Slovenia, Verovškova 57, 1526 Ljubljana, Slovenia., Lek d.d., Sandozov razvojni center Slovenija, Verovškova 57, 1526 Ljubljana, Slovenija.

    Ljubljana, Slovenia. E-mail: zdenko.casar@sandoz.com

Published

08.06.2022

Issue

Section

Prispevki

How to Cite

Čusak, A., Časar, Z., & Šterk, D. (2022). Use of allyl intermediate in novel synthetic route to rosuvastatin key heterocyclic building block: N-(4-(4-fluorophenyl)-5-formyl-6- isopropylpyrimidin-2-yl)-Nmethylmethanesulfonamide. Anali PAZU, 7(1-2), 18-23. https://doi.org/10.18690/analipazu.7.1-2.18-23.2017

Most read articles by the same author(s)